Evidence map›Paper›PMID 10094702›Full record

ArticleJournal of bacteriology1999

Mutations that confer resistance to 2-deoxyglucose reduce the specific activity of hexokinase from Myxococcus xanthus.

P Youderian, M C Lawes, C Creighton, J C Cook, M H Saier

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pectin lyase overproduction by Penicillium griseoroseum mutants resistant to catabolite repression.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

P YouderianDepartment of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052, USA. pay@uidaho.edu
M C Lawes
C Creighton
J C Cook
M H Saier
University of Idaho · USUniversity of California, San Diego · US

Funding

GENETICS OF MYXOPHAGESR01GM053392 · NIGMS · UNIVERSITY OF IDAHO · PI YOUDERIAN, PHILIP A · 1995 to 2003
$525k
MECHANISM OF CARBOHYDRATE TRANSPORT IN BACTERIAR01AI014176 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SAIER, MILTON H. · 1986 to 2000
$294k
NIAID NIH HHS AI14176NIGMS NIH HHS GM53392NIGMS NIH HHS R01 GM053392
6 · The paper itself

Abstract

The glucose analog 2-deoxyglucose (2dGlc) inhibits the growth and multicellular development of Myxococcus xanthus. Mutants of M. xanthus resistant to 2dGlc, designated hex mutants, arise at a low spontaneous frequency. Expression of the Escherichia coli glk (glucokinase) gene in M. xanthus hex mutants restores 2dGlc sensitivity, suggesting that these mutants arise upon the loss of a soluble hexokinase function that phosphorylates 2dGlc to form the toxic intermediate, 2-deoxyglucose-6-phosphate. Enzyme assays of M. xanthus extracts reveal a soluble hexokinase (ATP:D-hexose-6-phosphotransferase; EC 2.7.1.1) activity but no phosphotransferase system activities. The hex mutants have lower levels of hexokinase activities than the wild type, and the levels of hexokinase activity exhibited by the hex mutants are inversely correlated with the ability of 2dGlc to inhibit their growth and sporulation. Both 2dGlc and N-acetylglucosamine act as inhibitors of glucose turnover by the M. xanthus hexokinase in vitro, consistent with the finding that glucose and N-acetylglucosamine can antagonize the toxic effects of 2dGlc in vivo.

Indexed as

AcetylglucosamineDeoxyglucoseDrug Resistance, MicrobialEscherichia coliGene ExpressionGenes, BacterialGlucokinaseGlucosamineGlycerolHexokinaseMorphogenesisMutagenesisMyxococcus xanthusSpores, BacterialAcetylglucosamineDeoxyglucoseGlucokinaseGlucosamineGlycerolHexokinase

Identifiers

PMID10094702
PMCPMC93637
OpenAlexW2132914321

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.